ANKRD22 enhances breast cancer cell malignancy by activating the Wnt/β-catenin pathway via modulating NuSAP1 expression. (2021). Biomolecules and Biomedicine, 21(3), 294-304. https://doi.org/10.17305/bjbms.2020.4701